all huntleigh products Իսրայել - եբրայերեն - Ministry of Health

all huntleigh products

trunof - כלל האוכלוסיה - מיטות מזרונים ומערכות העברה לחולים

all cordis-europa n.v. products Իսրայել - եբրայերեն - Ministry of Health

all cordis-europa n.v. products

j-c healthcare ltd. - רופא - רדיולוגיה : צנתרים, שרווליות, בלונים, seriw ועזרים אחרים

לוטאטרה 370 MBqmL תמיסה לעירוי Իսրայել - եբրայերեն - Ministry of Health

לוטאטרה 370 mbqml תמיסה לעירוי

marshall isotope ltd, israel - lutetium (177lu) oxodotreotide - תמיסה לאינפוזיה - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide

לוטאטרה 370 MBqmL תמיסה לעירוי Իսրայել - եբրայերեն - Ministry of Health

לוטאטרה 370 mbqml תמיסה לעירוי

marshall isotope ltd, israel - lutetium (177lu) oxodotreotide - תמיסה לאינפוזיה - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide

היקמטין 0.25 מג Իսրայել - եբրայերեն - Ministry of Health

היקמטין 0.25 מג

novartis israel ltd - topotecan as hydrochloride - קפסולות ג'לטין קשיחות - topotecan as hydrochloride 0.25 mg - topotecan - topotecan - indicated for the treatment of patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.

אלימטה 500 מג Իսրայել - եբրայերեն - Ministry of Health

אלימטה 500 מג

eli lilly israel ltd, israel - pemetrexed - אבקה להכנת תמיסה לאינפוזיה - pemetrexed 500 mg/vial - pemetrexed - pemetrexed - alimta in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. alimta in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. alimta is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.alimta is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

אלימטה 500 מג Իսրայել - եբրայերեն - Ministry of Health

אלימטה 500 מג

eli lilly israel ltd, israel - pemetrexed - אבקה להכנת תמיסה לאינפוזיה - pemetrexed 500 mg/vial - pemetrexed - pemetrexed - alimta in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. alimta in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. alimta is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.alimta is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

אלימטה Իսրայել - եբրայերեն - Ministry of Health

אלימטה

eli lilly israel ltd, israel - pemetrexed - אבקה להכנת תמיסה לאינפוזיה - pemetrexed 100 mg/vial - pemetrexed - pemetrexed - alimta in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. alimta in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. alimta is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.alimta is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

נבלבין 20 מג Իսրայել - եբրայերեն - Ministry of Health

נבלבין 20 מג

padagis israel agencies ltd, israel - vinorelbine as tartrate - קפסולות - vinorelbine as tartrate 20 mg - vinorelbine - vinorelbine - for the treatment of non small cell lung cancer. for the treatment of advanced breast cancer.